Login / Signup
Prolonged response after the discontinuation of nivolumab after resistance to gefitinib.
Yuika Sasatani
Shinichiro Okauchi
Gen Ohara
Katsunori Kagohashi
Toshihiro Shiozawa
Published in:
The clinical respiratory journal (2019)
Keyphrases
</>
small cell lung cancer
epidermal growth factor receptor